Home Bharat Biotech gets a nod from DGCI for phase 3 trials of intranasal COVID-19 vaccine Bharat Biotech gets nod to conduct Phase 3 & booster trials of intranasal COVID-19 vaccine

Bharat Biotech gets nod to conduct Phase 3 & booster trials of intranasal COVID-19 vaccine

As against injectable vaccines, intranasal vaccine is claimed to be easy to administer during mass inoculation campaigns

As against injectable vaccines, intranasal vaccine is claimed to be easy to administer during mass inoculation campaigns

Prasad Sawant
Prasad Sawant
Prasad Sawant
Latest posts by Prasad Sawant (see all)

    BOOKS

    Dailymotion Facebook Instagram Paypal Soundcloud Telegram Twitter Youtube
    © 2021 PGurus | All rights reserved.
    error: Content is protected !!